Zynex Reports Fourth Quarter and Full Year 2023 Financial Results

February 29, 2024

https://www.prnewswire.com/news-releases/zynex-reports-fourth-quarter-and-full-year-2023-financial-results-302076379.html

FY 2023 Revenue Increased 17% to $184.3 Million

Company Announces Additional $20 Million Stock Repurchase Plan

ENGLEWOOD, Colo., Feb. 29, 2024 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported its financial and operational results for the fourth quarter and full year ended December 31, 2023 and its Board of Directors has approved an additional program to repurchase up to $20.0 million of the Company’s common stock.

Read more at prnewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.